About
Martin Tolar has served as a Director of BELLUS Health since October 2010 and is currently the President and Chief Executive Officer of Alzheon, a private biotechnology company. From January 2012 to October 2012, Tolar was President and Chief Executive Officer of Knome, a private life science company. Before joining Knome, Dr. Tolar held executive positions in pharmaceutical and biotechnology companies, including as Chief Executive Officer of NormOxys, where he successfully built and financed the business and advanced the company’s novel cancer therapeutics from a research project into clinical development. Prior to NormOxys, he was Chief Business Officer at CoMentis, where he led the company’s scientific and business growth and negotiated a landmark collaboration agreement with Astellas Pharma. Prior to CoMentis, Tolar held a variety of leadership positions at Pfizer in roles in clinical development and business development, in which he was instrumental in a wide range of busin
Position in the VCSift Database
- • 2 investors at Alzheon are tracked.
- • 44 investors hold the Founder, President & CEO role in VCSift. Martin Tolar is one of them.
- • 2,293 investors are based in Boston, Massachusetts, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Boston, US
Contact Information
Find more investors like Martin
Search Investors